(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

But there are indications that large swaths of corporate America are already beginning to sour on Trump, as concerns grow ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

The Citadel founder says that the US will lose out on international trade and the AI arms race as a result.

Klarna Bank, a Swedish fintech company known for its Buy Now, Pay Later service plans to embrace cryptocurrency after previously criticizing it.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/106.Ckjk1Vbt.js ...

CEOs, policymakers that we can't depend upon America, as our trading partner," the billionaire said. Ken Griffin now ranks ...

Citadel CEO Ken Griffin spoke out at the UBS Financial Services conference in Key Biscayne, Fla., on Tuesday, thanking Elon ...

The wide range and uneven application of import tariffs by President Donald Trump is causing unease among consumers and ...